Time to Take Control - Slingshot Biosciences | Clapboard Ad Archive
Time to Take Control, created for Slingshot Biosciences by Umault in 2023, is a sharp, purpose-built campaign aimed squarely at the pharmaceutical and healthcare research sector, foregrounding the critical importance of reliable on-demand cellular controls and cell lines for flow cytometry applications. Anchored by a direct, narrative-driven film asset that sits squarely in what Clapboard’s taxonomy identifies as FORMAT#2—Show the Problem, this effort takes the perennial pain point of unpredictable or insufficient cellular controls and elevates it from technical frustration to a call for professional empowerment, appealing to scientists and lab professionals who understand that experimental rigor lives or dies by the quality of their tools. The creative strategy is notable for its disciplined focus: the commercial eschews the flourishes of metaphor, narrative detours, or celebrity ambassadors in favor of a straightforward depiction of scientific roadblocks—lack of control, reliability, and standardization—before delivering Slingshot’s proprietary solution as the clarifying answer to these operational headaches. This approach sets Slingshot apart in a field where dominant players such as Bio-Rad Laboratories, Thermo Fisher Scientific, BD Biosciences, Miltenyi Biotec, and Luminex often compete on portfolio breadth, scale, or technical innovation, while here, the message is precision: true control, available on demand, with the implication that existing solutions frequently fall short of the flexible rigor today’s researchers require. By positioning itself not just as a provider, but as an enabler of scientific credibility and accelerated drug discovery, Slingshot Biosciences asserts a strong case for its relevance in R&D and clinical workflows. The deployment of a single, focused film narrative provides a clear contrast against the clutter often seen in the pharmaceutical communications environment, making strategy on-the-nose and the value proposition unmissable for its intended audience. The campaign’s tone is confident and intellectually direct, appealing to the expertise and ambitions of those who, daily, bear the responsibility for dependable scientific outputs, and it is precisely this editorial clarity—combined with the technical specificity of the product—that is designed to drive adoption among key decision-makers and influencers within pharmaceutical innovation. Clapboard rates this 60/100. In raising the bar for narrative precision and problem-solution clarity in laboratory and research communications, Time to Take Control reminds the category that essential ingenuity can be best expressed by speaking directly to the audience’s ambitions for mastery and reliability.